美國
US 12,702,717 B2
Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody
US 12,702,717 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：Sowakai Medical Foundation; National University Corporation Tokai National Higher Education and Research System。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- Sowakai Medical Foundation; National University Corporation Tokai National Higher Education and Research System
- 發明人
- Atsushi ENOMOTO; Nobutoshi ESAKI; Masahide TAKAHASHI; Yuki MIYAI; Ryota ANDO; Yukihiro SHIRAKI; Yoshihiro NISHIDA; Makoto MATSUYAMA; Shino MANABE
- 公開日
- 2026-08-11
- 申請日
- 2022-08-02
- 文件種類
- B2 核准公告
- 也寫作
- US 12,702,717 B2 · US12702717 · 12702717
摘要
An anti-MEFLIN antibody and a pharmaceutical composition comprising the antibody is described. The pharmaceutical composition may comprise an antibody-drug conjugate (ADC) of the anti-MEFLIN antibody and a cytotoxic agent, which may be connected to each other by a linker. The pharmaceutical composition may be used in the treatment of a cancer in a subject.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）